garenoxacin has been researched along with clorgyline in 1 studies
Studies (garenoxacin) | Trials (garenoxacin) | Recent Studies (post-2010) (garenoxacin) | Studies (clorgyline) | Trials (clorgyline) | Recent Studies (post-2010) (clorgyline) |
---|---|---|---|---|---|
195 | 19 | 46 | 1,075 | 23 | 170 |
Protein | Taxonomy | garenoxacin (IC50) | clorgyline (IC50) |
---|---|---|---|
Amine oxidase [flavin-containing] B | Rattus norvegicus (Norway rat) | 0.8602 | |
Amine oxidase [flavin-containing] A | Rattus norvegicus (Norway rat) | 0.5688 | |
Amine oxidase [flavin-containing] A | Homo sapiens (human) | 0.2574 | |
Amine oxidase [flavin-containing] A | Bos taurus (cattle) | 0.0032 | |
Amine oxidase [flavin-containing] B | Homo sapiens (human) | 3.6869 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cao, Z; Deng, Y; Li, Y; Luo, L; Qiang, X; Song, Q; Tan, Z; Xiao, G; Xu, R; Yang, X | 1 |
1 other study(ies) available for garenoxacin and clorgyline
Article | Year |
---|---|
Multifunctional thioxanthone derivatives with acetylcholinesterase, monoamine oxidases and β-amyloid aggregation inhibitory activities as potential agents against Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Cell Line; Cholinesterase Inhibitors; Humans; Kinetics; Models, Molecular; Monoamine Oxidase Inhibitors; Thioxanthenes; Xanthones | 2017 |